Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
about
Biochemical characterization of human collagenase-3The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interactionStructural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2.Zinc-dependent dimers observed in crystals of human endostatinThe metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidasesX-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: Implications for inhibitor selectivityStructural insights into triple-helical collagen cleavage by matrix metalloproteinase 1In Vitro and Cellular Self-Assembly of a Zn-Binding Protein Cryptand via Templated Disulfide BondsStructural differences of matrix metalloproteinases. Homology modeling and energy minimization of enzyme-substrate complexesThe intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modelingHydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastaseCloning and characterization of a novel matrix metalloproteinase (MMP), CMMP, from chicken embryo fibroblasts. CMMP, Xenopus XMMP, and human MMP19 have a conserved unique cysteine in the catalytic domainN-glycan structures of matrix metalloproteinase-1 derived from human fibroblasts and from HT-1080 fibrosarcoma cells.A unique substrate recognition profile for matrix metalloproteinase-2.Regulation and involvement of matrix metalloproteinases in vascular diseasesStructural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.The history of matrix metalloproteinases: milestones, myths, and misperceptions.Chronic obstructive pulmonary disease: role of matrix metalloproteases and future challenges of drug therapy.Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain.Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development.ADM-1, a protein with metalloprotease- and disintegrin-like domains, is expressed in syncytial organs, sperm, and sheath cells of sensory organs in Caenorhabditis elegans.Actinobacterial enzyme inhibitors--a review.Matrix metalloproteinase inhibitors: a patent review (2011 - 2013).Human protein kinase CK2 phosphorylates matrix metalloproteinase 2 and inhibits its activity.New biochemical insight of conserved water molecules at catalytic and structural Zn2+ ions in human matrix metalloproteinase-I: a study by MD-simulation.Regulation of proteolytic activity in tissues.A residue in the S2 subsite controls substrate selectivity of matrix metalloproteinase-2 and matrix metalloproteinase-9.Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?Retrospective analysis of a secondary structure prediction: the catalytic domain of matrix metalloproteinases.Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.Solution structures of stromelysin complexed to thiadiazole inhibitors.Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors.Design and synthesis of substrate-based inhibitors of botulinum neurotoxin type B metalloprotease.Pivotal molecular determinants of peptidic and collagen triple helicase activities reside in the S3' subsite of matrix metalloproteinase 8 (MMP-8): the role of hydrogen bonding potential of ASN188 and TYR189 and the connecting cis bond.Characterization of the Phe-81 and Val-82 human fibroblast collagenase catalytic domain purified from Escherichia coli.Structural and enzymatic characterization of Drosophila Dm2-MMP, a membrane-bound matrix metalloproteinase with tissue-specific expression.Effect of species differences on stromelysin-1 (MMP-3) inhibitor potency. An explanation of inhibitor selectivity using homology modeling and chimeric proteins.Zinc Metabolism and Metallothioneins.Matrix metalloproteinase inhibitors in arthritis.
P2860
Q24318765-F7690200-A0D2-4ED1-8521-06F879C12DB4Q24336413-8B73EC75-D88F-4D2D-913E-BB3D80D3B26BQ24530532-0166DA81-0CF6-4848-A2CE-D9120D08872AQ24644126-A5D4B117-F820-421F-B3D4-6BBEF3B75977Q24675153-CE49407A-38EF-43EB-B293-7EEE1AE8D11EQ27619131-955937B2-E4F6-497C-AB4E-46D60038A249Q27670630-F1A4E721-C054-448A-A2AF-2FF723E4E7E8Q27679319-313EC211-1AC7-419D-8882-025EEB795154Q28144131-1001F8BF-B4D9-45FF-AE2C-75DB01240C74Q28207951-B3129876-FFB2-45AF-B65A-D99E5D8630A0Q28235879-C87A6DFB-40D6-49D9-8486-07FA59A0520FQ28610368-C1B72C9F-AC85-476D-A34D-3AA480FD9FDBQ30657326-B2EFD3DA-BBD3-4D6A-84FB-02F25AD3A2B8Q30761477-1259AC96-6B79-4B86-91EF-2393ACD61358Q33773304-37FDEC5C-5CDA-4B40-A5D6-E94B502DF3F8Q35187217-90AFFE6C-111A-4D86-BF29-53D9EBF95515Q36279009-DCE92DCB-51A1-4C8B-874C-133CDD791103Q36312509-EFA43CC4-F9C5-4771-BFEF-8EDF70252ED6Q36861614-32213B04-53E5-4F51-BCCE-DB729D51B23EQ36885449-9352994F-93A7-413F-8473-2CB3ED04A082Q37382599-9209D068-66AC-4460-B1B7-CEC724CE145DQ37383656-317E0E45-F756-4282-B8A3-56116D39F5F0Q38185118-2F1D8684-46ED-4220-B467-97BA2A89C3E6Q38237471-501B4F05-1926-480B-91B3-BCACBBEDE348Q38973538-0757B69D-7E84-4F53-ADD2-A114602F1A4EQ38978663-C5FBAC99-B334-4289-AA81-40834B69F03EQ40575091-9E6CE28D-56BC-4E6F-82CC-2DFCC3681BD5Q40669960-CB7E3516-6544-4398-B95B-7B20993CB5CDQ40848847-7EAD40CB-1F8C-426E-9CC0-EB21BC336573Q41833294-98E240FE-0D26-4C21-85A5-D13FCA932DACQ42041891-95AA1897-09AE-4FAC-A7B0-23D32C65141EQ42846171-E5D9F8B1-3864-4858-AAF3-C6E1418C2916Q43760509-CB388E38-66B4-4567-99DA-DC21DDE42FDBQ44781084-506D4CB3-12E1-48A7-BF91-97674979AC1FQ45144490-BD1315AE-225B-4210-BA17-2FCFC8B59D90Q46103790-E4A3E5C4-AF90-4BA9-86F8-728EF0D7FCDCQ47071821-AD421052-EA91-4E17-A36A-18E716AF59D4Q47936331-9D0229C2-BBDB-4E98-9CFC-1764607969F8Q47947185-A5B4950E-E4E3-4D64-8E11-F86AA9F387BDQ47965876-3C0259B5-2010-42E2-B458-598366F9B774
P2860
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
@ast
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
@en
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
@nl
type
label
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
@ast
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
@en
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
@nl
prefLabel
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
@ast
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
@en
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
@nl
P2093
P356
P1433
P1476
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
@en
P2093
A B McElroy
A M Hassell
G McGeehan
M A Luther
M H Lambert
P356
10.1126/SCIENCE.8278810
P407
P577
1994-01-21T00:00:00Z